Level Four Advisory Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Level Four Advisory Services’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,162	Closed	-$215K	–	596
2019 Q4	$215K	Buy	+1,162	New	+$130K	0.01%	532
2019 Q3	–	Sell	-1,262	Closed	-$218K	–	548
2019 Q2	$218K	Buy	1,262 +61	+5%	+$10.6K	0.02%	484
2019 Q1	$202K	Buy	+1,201	New	+$179K	0.02%	486

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Level Four Advisory Services's GWPH Position: Q1 2020 in Review

Level Four Advisory Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 1,162 shares — an estimated $215K sold.

Level Four Advisory Services first reported a position in GWPH in Q1 2019 and held it in 3 quarters. The position peaked at $218K in Q2 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Level Four Advisory Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Level Four Advisory Services sold 1,162 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $215K.
Level Four Advisory Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 3 quarters.
Level Four Advisory Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $218K in Q2 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Level Four Advisory Services's 13F filing for Q1 2020, filed 13 May 2020.